Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma
Trodelvy has shown encouraging activity in an early-stage study in brain cancers, including partial responses in small cohorts of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Immunomedics
Trodelvy from Immunomedics extends survival in breast cancer patients
The FDA granted the drug accelerated approval for its use in metastatic triple-negative breast cancer (mTNBC) patients who had…
Gilead may soon buy Immunomedics in deal over $20 billion
The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports
FDA approves new therapy for triple negative breast cancer that has spread, not responded to other…
The FDA granted approval of Trodelvy to Immunomedics